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Summary and Implications 
In the present study, 30 Holstein calves were acquired 
at birth and were randomly subjected to one of six 
treatments.  One treatment group was colostrum deprived 
(CD) and five other treatment groups were fed colostrum 
replacer (CR).  Of the five CR groups, one group was not 
further supplemented (CR), one received vitamin A (CR-A), 
one received vitamin D (CR-D), one received vitamin E 
(CR-E), and one received vitamins A, D, and E (CR-ADE).  
Additionally, all calves were inoculated with 
Mycobacterium avium, subsp. paratuberculosis on d 1 and d 
3 of age.  One d after birth, CD calves exhibited lower IgG1, 
haptoglobin, and serum amyloid A concentrations in serum 
compared with the other five CR groups.  These findings 
point to an endogenous early inflammation disorder in 
calves that are not fed colostrum.  
 
Introduction 
The passive benefits of colostrum intake by neonatal 
calves are well described and are primarily attributed to 
acquisition of exogenous immunoglobulin, but recently 
interest has been generated regarding effects of bioactive 
compounds in colostrum on endogenous functions.  
Endogenous immune capabilities are especially important 
during early life when microbial colonization of the 
intestine takes place.  Colostrum contains fat soluble 
vitamins that have been implicated in intestinal barrier and 
immune response functions.  The aim of this study was to 
assess the effects of colostrum supplementation and 
additional supplemental vitamins A, D, and E on intestinal 
health in neonatal calves. 
 
Materials and Methods 
Animal Procedures 
All procedures were approved by the animal care and 
use committee of the National Animal Disease Center, ARS, 
USDA (Ames, IA 50010). Thirty Holstein calves were 
obtained from two dairy farms in central Iowa and were 
randomly assigned to one of six treatment groups, with 5 
calves per treatment, in a 14 d feeding trial.  One treatment 
group was colostrum deprived (CD), and the other five 
treatment groups received 375 g of colostrum replacer (Milk 
Products, Chilton, WI 53014) reconstituted in 1.9 L water at 
approximately 40 degrees C.  The colostrum replacer 
contained 150 g bovine globulin protein from fractionated 
colostral whey.  Calves in the CD group were fed 1.9 L of 
pasteurized whole milk (Iowa State University Dairy Farm, 
Ames, IA 50014) brought to approximately 40 degrees C as 
a control.  All calves received first feeding within 3 h of 
birth.  
All calves received one of six vitamin or control 
treatments at the time of first feeding.  Calves in the CD 
group were injected with 3 mL of placebo carrier solution.  
Similarly, one group fed colostrum replacer (CR) was also 
injected with 3 mL of placebo carrier solution.  The other 
four treatment groups received colostrum replacer as 
described and then were injected with various vitamin 
solutions (Stuart Products, Bedford, TX) in a 3 mL volume.  
The CR-A group received 150,000 I.U. of retinyl palmitate, 
the CR-D group received 150,000 I.U. of cholecalciferol, 
the CR-E group received 1,500 I.U. of d-α-tocopherol, and 
the CR-ADE group received all three compounds in the 
concentrations described. 
Calves were transported within 12 h of birth to 
experimental indoor housing at the National Animal Disease 
Center.  Upon arrival, calves were placed on a twice daily 
feeding schedule.  At each feeding, calves were fed 2.7 L of 
pasteurized whole milk.  Once per day, calves received 
additional vitamin supplementation according to treatment 
group in 1 mL volume, consisting of placebo, 25,000 I.U. 
retinyl palmitate, 5,000 I.U. cholecalciferol, 500 I.U. d-α-
tocopherol, or the triad combination.  All calves were 
offered milk via bottle and nipple, but calves were not 
allowed to refuse dietary milk; refusals of greater than 0.1 L 
were administered to the calf via esophageal tube.  Day 1 of 
the trial was marked by the first morning feeding in the trial 
location.  All calves were inoculated via dietary milk with 
10^8 cfu of Mycobacterium avium, subsp. paratuberculosis, 
which is the causative agent of Johne’s disease, during the 
morning feedings of d 1 and d 3.  Calves were fed according 
to schedule for 14 d. 
 
Sample collection and analysis 
Whole blood was collected via jugular venipuncture 
from all animals on d 0 within four hours of birth and again 
on d 1 at 12 to 24 h post-partum, on d 7, and on d 14 after a 
12 h fast.  Blood was allowed to clot at room temperature 
for 1 h, and then was centrifuged at 2500 RPM for 30 min 
for collection of serum.  Haptoglobin was quantified using a 
bovine-specific haptoglobin ELISA (Immunology 
Consultants Laboratory Inc., Newberg OR).  Serum amyloid 
A (SAA) was quantified using the PHASETM RANGE 
Multispecies SAA ELISA kit (Tridelta Development Ltd., 
Maynooth Co. Kildare, Ireland).  Immunoglobulin G1 
concentration was quantified by capture ELISA using sheep 
anti-Bovine IgG1 antibody (Bethyl Laboratories, Inc., 
Montgomery, TX 77356) and sheep anti-Bovine IgG1-HRP 
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conjugate (Bethyl Laboratories, Inc.) for catalysis of tri-
methyl blue (TMB) colorimetric reaction.   
Retinol and α-tocopherol were quantified by reverse 
phase high performance liquid chromatography (RP-HPLC) 
using a SUPELCOSILTM LC-18DB HPLC column (5 µm 
particle size, dimensions 25 cm x 4.6 mm, Sigma-Aldrich) 
after extraction from serum using hexane as a solvent using 
retinyl acetate (125 ng suspended in 200 uL ethyl alcohol) 
as the internal standard.   
Total 25-(OH)-Vitamin D2 and D3 equivalents were 
quantified by competitive radioimmunoassay after 
extraction using acetonitrile.  Radioiodinated 25-(OH)-
vitamin D (Diasorin) was used as an internal standard 
(10,000 cpm in 25 uL ethanol with addition of 0.01 M 
phosphate). Gamma radiation of samples was counted using 
a gamma-radiation well-type counting system (Packard 
Cobra II gamma counter, GMI, Ramsey, MN 55303).  
Concentration of 25-(OH)-vitamin D equivalents for each 
sample was determined directly by the counting system.   
 
Statistical Analysis 
Data for vitamin concentrations in serum were analyzed 
by repeated measures ANOVA using mixed procedures of 
SAS (version 9.3, SAS Institute Inc., Cary, NC).  Calf 
served as the experimental unit.  The model included fixed 
effects of treatment and sample day; calf was included in the 
model as a random effect.  Contrast statements were used to 
separate least square means of calves supplemented with 
each respective vitamin from calves not supplemented with 
the vitamin. 
Data for acute phase proteins were initially analyzed by 
repeated measures ANOVA as described, but disparity 
among standard error values for individual treatment means 
rendered the model invalid, so d 1 values for acute phase 
proteins were analyzed as a unique response variable using 
contrast statements in mixed procedures of SAS.  Contrast 
statements were used as described to separate least square 
means on the basis of vitamin supplementation.  An 
additional contrast statement was used to separate least 
square means of the CD group and the five CR groups.  
Data for IgG1 at d 1 were analyzed similarly, using only a 
contrast statement to separate means on the basis of 
colostrum supplementation.  
 
Results and Discussion 
Treatment verification 
To determine success of colostrum and vitamin 
treatments, IgG1, retinol, 25-(OH)-cholecalciferol, and 
tocopherol were quantified in serum.  Values are reported as 
mean + pooled standard error.  Calves supplemented with 
colostrum at first feeding (CR, CR-A, CR-D, CR-E, CR-
ADE) all exhibited greater concentrations of IgG1 in serum 
by d 1 of age (Figure 1).  The statistical contrast of d 1 IgG1 
values of CR groups against the CD groups produced a P 
value of <0.0001.  Treatment group averages for IgG1 in 
serum at d 1 did not exceed 6.0 mg/mL for any group. 
Calves supplemented with retinyl acetate individually 
(CR-A) and as part of the triad vitamin treatment (CR-ADE) 
exhibited greater overall concentrations of retinol in serum 
when contrasted against treatment groups not supplemented 
with retinyl acetate (P < 0.05).  Figure 2 shows mean 
concentrations of retinol in serum of all treatment groups at 
all of the time points tested.  Mean concentration of retinol 
in serum did not differ between the CR-A and CR-ADE 
groups at any of the time points tested.  
Calves supplemented with cholecalciferol individually 
(CR-D) and as part of the triad vitamin treatment (CR-ADE) 
exhibited greater overall concentrations of 25-(OH)-vitamin 
D equivalents when statistically contrasted against calves 
that did not receive the cholecalciferol supplement (P < 
0.0001).  Figure 3 shows mean concentrations of 25-(OH)-
vitamin D equivalents in serum of all treatment groups at all 
of the time points tested.  Additionally, CR-ADE calves 
exhibited greater 25-(OH)-vitamin D in serum at d 7 than 
did CR-D calves (P < 0.0001), but the difference was not 
observed at d 14.  Concentration of 25-(OH)-vitamin D in 
serum of calves not supplemented with the compound 
declined below 20.0 ng/mL by 14 d of age, indicative of 
severe vitamin D deficiency.  
Calves supplemented with d-α-tocopherol individually 
(CR-E) and as part of the triad treatment (CR-ADE) also 
exhibited greater overall concentrations of α-tocopherol in 
serum throughout the study period (P < 0.0001).  Figure 4 
shows mean concentrations of α-tocopherol in serum of all 
treatment groups at all of the time points tested.  Mean 
concentration of α-tocopherol did not differ between CR-E 
and CR-ADE calves at any of the time point tested. 
 
Acute Phase Inflammation 
Acute phase inflammatory proteins haptoglobin and 
serum amyloid A (SAA) were quantified in serum of calves 
at d 0, 1, 7, and 14 to test the hypothesis that colostrum and 
vitamin supplementation of various forms would affect 
initial immune responses to first microbial encounter after 
birth and also later responses indicative of the degree of 
homeostasis maintained with intestinal and environmental 
microbiota.  Panel A in Figures 5 and 6 show mean + 
pooled standard error concentrations of haptoglobin and 
serum amyloid A, respectively, in serum of all treatment 
groups at all four of the time points analyzed by repeated 
measures ANOVA.  The repeated measures ANOVA 
revealed no overall effect of treatment, but a significant 
effect of day (P < 0.05), on stimulation of haptoglobin 
expression; the same outcome was observed for SAA (P < 
0.0001).  Furthermore, standard errors of individual 
treatment means for d 1 haptoglobin values were orders of 
magnitude smaller than standard errors of treatment means 
for d 7 and d 14 values (data not shown).  The results are 
consistent with our working hypothesis that immediate post-
natal immune responses that stimulate inflammation may be 
of a different nature than the responses that have been 
characterized for traditional pathogen challenge.  Thus, we 
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determined that the repeated measures ANOVA was not 
robust to early postnatal (d 1) values for the acute phase 
response, so d 1 values were analyzed as a unique response 
variable.  The fixed effect of treatment in the model tended 
to be significant (P < 0.1) for both haptoglobin and SAA 
and therefore warranted further statistical contrasts 
according to colostrum and vitamin treatments. 
Colostrum deprivation (CD) was contrasted against the 
other five CR treatments for effect on concentrations of 
haptoglobin and serum amyloid A in serum of calves at d 1.  
Panel B of Figures 5 and 6 shows mean concentrations + 
pooled standard error of the contrast for haptoglobin and 
serum amyloid A.  Calves supplemented with colostrum 
replacer as part of experimental treatment exhibited 
approximately 6-fold greater concentrations of haptoglobin 
at d 1 (P < 0.01) and 2-fold greater concentrations of serum 
amyloid A (P < 0.05) than did CD calves.  Calves 
supplemented with the various vitamins were contrasted 
against the unsupplemented treatment groups as previously 
described, but no significant differences were detected.  
Thus, differences in acute phase protein expression at d 1 
are independent of vitamin supplementation.  
Every previously characterized aspect of colostrum 
supplementation is an asset to the newborn calf.  Therefore, 
induction of haptoglobin and serum amyloid at d 1 of age in 
calves fed colostrum should be viewed as a positive event 
and indicates that inflammation is a normal and necessary 
adjustment to the ex-utero environment.  Additionally, these 
results indicate that failure to express acute phase 
inflammatory proteins is associated with humoral 
immunodeficiency as a result of colostrum deprivation.  
Thus, we identify the endogenous condition of early 
inflammation disorder separately from failure of passive 
acquisition of humoral immunity and we characterize it as 
independent of vitamin supplementation. 
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Figure 1.  Mean concentrations of IgG1 in serum of calves 12-24 h post-partum. 
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Figure 2.  Mean concentrations of retinol in serum of calves. 
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Figure 3.  Mean concentrations of 25-(OH)-vitamin D equivalents in serum of calves. 
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Figure 4.  Mean concentrations of α-tocopherol in serum of calves. 
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Figure 5.  Concentrations of haptoglobin in serum of calves a) for all time points analyzed by repeated measures 
ANOVA and b) for d 1 values analyzed by statistical contrast.  *P < 0.01. 
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Figure 6.  Concentrations of serum amyloid A in serum of calves a) for all time points analyzed by repeated measures 
ANOVA and b) for d 1 values analyzed by statistical contrast. *P < 0.05. 
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